neoeriocitrin has been researched along with shikonin in 1 studies
| Studies (neoeriocitrin) | Trials (neoeriocitrin) | Recent Studies (post-2010) (neoeriocitrin) | Studies (shikonin) | Trials (shikonin) | Recent Studies (post-2010) (shikonin) |
|---|---|---|---|---|---|
| 12 | 0 | 11 | 660 | 2 | 505 |
| Protein | Taxonomy | neoeriocitrin (IC50) | shikonin (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.1392 | |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | 6.6 | |
| Pyruvate kinase PKM | Homo sapiens (human) | 6.2933 | |
| M-phase inducer phosphatase 1 | Homo sapiens (human) | 0.22 | |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | 0.4 | |
| DNA topoisomerase 2-beta | Homo sapiens (human) | 6.6 | |
| Class A sortase SrtA | Staphylococcus aureus | 2.65 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
1 other study(ies) available for neoeriocitrin and shikonin
| Article | Year |
|---|---|
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |